325 related articles for article (PubMed ID: 19835601)
1. Family physician attitudes about prescribing using a drug formulary.
Suggs LS; Raina P; Gafni A; Grant S; Skilton K; Fan A; Szala-Meneok K
BMC Fam Pract; 2009 Oct; 10():69. PubMed ID: 19835601
[TBL] [Abstract][Full Text] [Related]
2. Prescribing and drug costs in the province of Ontario.
Lexchin J
Int J Health Serv; 1992; 22(3):471-87. PubMed ID: 1644510
[TBL] [Abstract][Full Text] [Related]
3. A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing.
Prosser H; Walley T
Soc Sci Med; 2005 Mar; 60(6):1335-46. PubMed ID: 15626528
[TBL] [Abstract][Full Text] [Related]
4. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey.
Watkins C; Harvey I; Carthy P; Moore L; Robinson E; Brawn R
Qual Saf Health Care; 2003 Feb; 12(1):29-34. PubMed ID: 12571342
[TBL] [Abstract][Full Text] [Related]
5. Physicians' opinions about responsibility for patient out-of-pocket costs and formulary prescribing in two Midwestern states.
Khan S; Sylvester R; Scott D; Pitts B
J Manag Care Pharm; 2008 Oct; 14(8):780-9. PubMed ID: 18983207
[TBL] [Abstract][Full Text] [Related]
6. Physicians, pharmaceutical sales representatives, and the cost of prescribing.
Caudill TS; Johnson MS; Rich EC; McKinney WP
Arch Fam Med; 1996 Apr; 5(4):201-6. PubMed ID: 8769907
[TBL] [Abstract][Full Text] [Related]
7. Health information technology and physicians' knowledge of drug costs.
Tseng CW; Brook RH; Alexander GC; Hixon AL; Keeler EB; Mangione CM; Chen R; Jackson EA; Dudley RA
Am J Manag Care; 2010 Apr; 16(4):e105-10. PubMed ID: 20370310
[TBL] [Abstract][Full Text] [Related]
8. Delisting of drugs in Ontario. How attitudes and prescribing strategies of family physicians in the Kingston area changed.
Godwin M; Chapman J; Mowat D; Racz W; McBride J; Tang J
Can Fam Physician; 1996 Jul; 42():1309-16. PubMed ID: 8754700
[TBL] [Abstract][Full Text] [Related]
9. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
Gurwitz JH; McLaughlin TJ; Fish LS
Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
[TBL] [Abstract][Full Text] [Related]
10. Physicians' willingness and barriers to considering cost when prescribing.
Tseng CW; Buenconsejo-Lum L; Manlucu L; Hixon A
Hawaii Med J; 2006 Nov; 65(11):318, 320-1. PubMed ID: 17265992
[TBL] [Abstract][Full Text] [Related]
11. Improving Physician Knowledge: A Necessary but Not Sufficient Requirement of Improving Intrauterine Contraception Access in Canada.
Howatt K; Binette A; Pudwell J; Waddington A
J Obstet Gynaecol Can; 2019 Aug; 41(8):1115-1124. PubMed ID: 30803875
[TBL] [Abstract][Full Text] [Related]
12. Introducing a drug formulary to general practice--effects on practice prescribing costs.
Beardon PH; Brown SV; Mowat DA; Grant JA; McDevitt DG
J R Coll Gen Pract; 1987 Jul; 37(300):305-7. PubMed ID: 3449632
[TBL] [Abstract][Full Text] [Related]
13. Rural physicians' perspectives on cervical and breast cancer screening: a gender-based analysis.
Ahmad F; Stewart DE; Cameron JI; Hyman I
J Womens Health Gend Based Med; 2001 Mar; 10(2):201-8. PubMed ID: 11268303
[TBL] [Abstract][Full Text] [Related]
14. AMCP Partnership Forum: What's Next for Specialty Medication Benefit Design and Reimbursement.
J Manag Care Spec Pharm; 2020 Oct; 26(10):1206-1213. PubMed ID: 32780612
[TBL] [Abstract][Full Text] [Related]
15. Is There a Tension between Clinical Practice and Reimbursement Policy? The Case of Osteoarthritis Prescribing Practices in Ontario.
Raina PS; Gafni A; Bell S; Grant S; Sebaldt RJ; Fan A; Petrie A; Skilton K
Healthc Policy; 2007 Nov; 3(2):e128-44. PubMed ID: 19305773
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the impact of a novel restricted reimbursement policy for quinolone antibiotics: a time series analysis.
Manns B; Laupland K; Tonelli M; Gao S; Hemmelgarn B
BMC Health Serv Res; 2012 Aug; 12():290. PubMed ID: 22935100
[TBL] [Abstract][Full Text] [Related]
17. The impact of a national prescription drug formulary on prices, market share, and spending: lessons for Medicare?
Huskamp HA; Epstein AM; Blumenthal D
Health Aff (Millwood); 2003; 22(3):149-58. PubMed ID: 12757279
[TBL] [Abstract][Full Text] [Related]
18. Dutch GPs' perceptions: the influence of out-of-pocket costs on prescribing.
Kasje WN; Timmer JW; Boendermaker PM; Haaijer-Ruskamp FM
Soc Sci Med; 2002 Nov; 55(9):1571-8. PubMed ID: 12297243
[TBL] [Abstract][Full Text] [Related]
19. Determinants of prescribing costs amongst single-handed general practitioners.
Gill PS; Roalfe A
J Clin Pharm Ther; 2001 Dec; 26(6):433-5. PubMed ID: 11722680
[TBL] [Abstract][Full Text] [Related]
20. Family Physician Perceptions of Their Role in Managing the Opioid Crisis.
Desveaux L; Saragosa M; Kithulegoda N; Ivers NM
Ann Fam Med; 2019 Jul; 17(4):345-351. PubMed ID: 31285212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
